XH, Y., Y, L., CS, F., HM, J., & ZB, Y. (2026). Therapeutic monoclonal antibodies for diabetic kidney disease: A narrative review from basic mechanisms to clinical evidence. Frontiers in endocrinology, 17, 1868198. https://doi.org/10.3389/fendo.2026.1868198
Chicago Style (17th ed.) CitationXH, Yang, Liu Y, Fu CS, Jin HM, and Ye ZB. "Therapeutic Monoclonal Antibodies for Diabetic Kidney Disease: A Narrative Review from Basic Mechanisms to Clinical Evidence." Frontiers in Endocrinology 17 (2026): 1868198. https://doi.org/10.3389/fendo.2026.1868198.
MLA (9th ed.) CitationXH, Yang, et al. "Therapeutic Monoclonal Antibodies for Diabetic Kidney Disease: A Narrative Review from Basic Mechanisms to Clinical Evidence." Frontiers in Endocrinology, vol. 17, 2026, p. 1868198, https://doi.org/10.3389/fendo.2026.1868198.